Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Publication year range
1.
Gynecol Oncol ; 110(3 Suppl 2): S45-8, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18678399

ABSTRACT

Locally advanced cervical carcinoma had been treated with radiation therapy until 1999, when five different large clinical trials showed an overall survival benefit when chemotherapy was administered concomitantly with radiotherapy. The chemotherapy agents used in these trials were cisplatin, cisplatin combined with fluorouracil or hydroxyurea. Weekly cisplatin (40 mg/m(2)) achieved the best responses, even when compared with the combination with fluorouracil. These results led the United States National Cancer Institute (NCI) to recommend platinum-based chemotherapy for the treatment of locally advanced cervical carcinoma. Other cytotoxic agents have been tried in combination with radiotherapy for the management of the disease, including carboplatin, paclitaxel, gemcitabine and even topotecan. Gemcitabine has shown promising results and the combination of paclitaxel and carboplatin has proved safe and effective. However, to date, there has been no agent or combination of agents to have shown superiority over weekly cisplatin. Biologic agents such as bevacizumab, cetuximab, sorafenib and erlotinib are currently being tried in different trials in combination with radiotherapy and cisplatin. Celecoxib, a COX-2 inhibitor was evaluated in an RTOG study in combination with cisplatin and flourouracil with radiation therapy with no apparent effect on DFS and poor rates of locoregional control. Chemoradiation is the current standard therapy in locally advanced cervical carcinoma. The integration of novel agents will be established by the ongoing clinical trials.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Uterine Cervical Neoplasms/drug therapy , Uterine Cervical Neoplasms/radiotherapy , Combined Modality Therapy , Female , Humans
2.
Clín. investig. ginecol. obstet. (Ed. impr.) ; 29(9): 349-350, nov. 2002. ilus
Article in Spanish | IBECS | ID: ibc-115347

ABSTRACT

Los embarazos heterotópicos son inusuales y su incidencia aumenta cuando se utilizan agentes inductores de la ovulación. El diagnóstico temprano de los mismos es difícil y en la mayoría de los casos se llega a producir un hemoperitoneo. Ante situaciones de dolor abdominal y gestación intrauterina se debe pensar en esta posibilidad. El embarazo ectópico será tratado quirúrgicamente dejando progresar el intrauterino. Los resultados son excelentes, consiguiéndose en un alto porcentaje de casos la evolución normal de la gestación intrauterina (AU)


Subject(s)
Humans , Female , Adult , Pregnancy, Heterotopic/diagnosis , Abdomen, Acute/etiology , Laparoscopy , Salpingectomy , Hemoperitoneum/etiology , Pregnancy, Twin
SELECTION OF CITATIONS
SEARCH DETAIL
...